Department of Internal Medicine, Østfold Hospital Trust, Grålum, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
J Thromb Haemost. 2018 Dec;16(12):2471-2481. doi: 10.1111/jth.14314. Epub 2018 Nov 20.
Essentials The aim of deep vein thrombosis (DVT) diagnostic work-up is to maximize both safety and efficiency. We explored whether D-dimer is safe and efficient as a stand-alone test to exclude DVT. Our findings suggest it is a safe, efficient and simplified diagnostic strategy. The safety of age-adjusted D-dimer as a stand-alone test requires further investigation. SUMMARY: Background Several strategies for safely excluding deep vein thrombosis (DVT) while limiting the number of imaging tests have been explored. Objectives To determine whether D-dimer testing could safely and efficiently exclude DVT as a stand-alone test, and evaluate its performance as compared with strategies that incorporate the Wells score and age-adjusted D-dimer. Patients/Methods We included consecutive outpatients referred with suspected DVT to the Emergency Department at Østfold Hospital, Norway. STA-Liatest D-Di PLUS D-dimer was analyzed for all patients. Patients with a D-dimer level of ≥ 0.5 μg mL were referred for compression ultrasonography (CUS). In patients with a D-dimer level of < 0.5 μg mL , no further testing was performed and anticoagulation was withheld. Patients were followed for 3 months for venous thromboembolism (VTE). Results Of the 913 included patients, 298 (33%) had a negative D-dimer result. One hundred and seventy-three patients (18.9%) were diagnosed with DVT at baseline. One of 298 patients had DVT despite having a negative D-dimer result, resulting in a failure rate of 0.3% (95% confidence interval [CI] 0.1-1.9%). Adding the modified Wells score would have yielded a failure rate of 0.0% (95% CI 0.0-1.8%) while necessitating 87 more CUS examinations. Age-adjusted D-dimer as a stand-alone test would have necessitated 80 fewer CUS examinations than fixed D-dimer as a stand-alone test, at the cost of a failure rate of 1.6% (95% CI 0.7-3.4%). Conclusions This outcome study shows that a negative high-sensitivity D-dimer result safely excludes DVT in an outpatient population, and necessitates fewer CUS than if used in combination with Wells score. The safety of stand-alone age-adjusted D-dimer needs further assessment in prospective outcome studies.
目的 探索 D-二聚体能否作为单独检测手段安全、有效地排除深静脉血栓形成(DVT)。 方法 我们纳入了挪威奥斯特福德医院急诊科疑似 DVT 的连续门诊患者。所有患者均检测 STA-Liatest D-Di PLUS D-二聚体。D-二聚体水平≥0.5μg/mL 的患者行加压超声检查(CUS)。D-二聚体水平<0.5μg/mL 的患者不进行进一步检测,且不给予抗凝治疗。患者接受 3 个月的静脉血栓栓塞症(VTE)随访。 结果 913 例患者中,298 例(33%)D-二聚体结果为阴性。173 例(18.9%)患者在基线时被诊断为 DVT。298 例阴性 D-二聚体结果患者中,有 1 例仍发生 DVT,漏诊率为 0.3%(95%置信区间[CI]0.1%-1.9%)。若增加改良 Wells 评分,漏诊率将为 0.0%(95%CI0.0%-1.8%),但需要多做 87 次 CUS 检查。单独使用年龄校正 D-二聚体作为检测手段,与单独使用固定 D-二聚体相比,需要的 CUS 检查少 80 次,但漏诊率为 1.6%(95%CI0.7%-3.4%)。 结论 本研究表明,门诊患者中,高敏 D-二聚体阴性结果可安全排除 DVT,且与 Wells 评分联合使用相比,D-二聚体检查次数更少。单独使用年龄校正 D-二聚体的安全性需要进一步的前瞻性研究来评估。